 CARLSBAD, Calif., Feb. 22, 2021 GLOBE NEWSWIRE -- GenMark Diagnostics, Inc. NASDAQ: GNMK, a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that its ePlex Respiratory Pathogen Panel 2 RP2 is predicted to detect known SARS-CoV-2 variants currently in circulation. 